Advanced in Chronic Spontaneous Urticaria (CSU)

Dr. Brad H. Goodman

Allergy and Immunology
790 Church Street Northeast, Suite 150, 
Marietta, GA 
Accepting New Patients
Offers Telehealth
Advanced in Chronic Spontaneous Urticaria (CSU)
790 Church Street Northeast, Suite 150, 
Marietta, GA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Brad Goodman is an Allergy and Immunologist in Marietta, Georgia. Dr. Goodman is rated as an Advanced provider by MediFind in the treatment of Chronic Spontaneous Urticaria (CSU). His top areas of expertise are Nonallergic Rhinopathy, Ozena, Sinusitis, and Allergic Rhinitis. Dr. Goodman is currently accepting new patients.

His clinical research consists of participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Emory University School Of Medicine, 1992
Residency
University of Texas School of Medicine, Pediatrics, 1995
Specialties
Allergy and Immunology
Licenses
Allergy & Immunology in GA
Board Certifications
American Board Of Allergy And Immunology
Fellowships
Baylor College of Medicine, Texas Children's Hospital, Allergy and Immunology, 1997
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Clover Health
  • INSURANCE PLAN
  • MEDICARE MAPD
Friday Health

Accepted plan types not found. Please verify directly with the provider.

Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
VIVA Health
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 17 Less Insurance Carriers -

Locations

Atlanta Allergy & Asthma
790 Church Street Northeast, Suite 150, Marietta, GA 30060

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Randomised, Double-blind, Parallel Group, Multicentre, Stratified, Study Evaluating the Efficacy and Safety of Once Daily Fluticasone Furoate/Vilanterol Inhalation Powder Compared to Once Daily Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Participants Aged 5 to 17 Years Old (Inclusive) Currently Uncontrolled on Inhaled Corticosteroids
A Randomised, Double-blind, Parallel Group, Multicentre, Stratified, Study Evaluating the Efficacy and Safety of Once Daily Fluticasone Furoate/Vilanterol Inhalation Powder Compared to Once Daily Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Participants Aged 5 to 17 Years Old (Inclusive) Currently Uncontrolled on Inhaled Corticosteroids
Enrollment Status: Completed
Publish Date: June 22, 2025
Intervention Type: Drug
Study Drugs: Fluticasone Furoate, Vilanterol
Study Phase: Phase 3
A 52-week, Randomised, Double-blind, Placebo-controlled, Parallel-group, Multi-centre Study of the Efficacy and Safety of GSK3511294 Adjunctive Therapy in Adult and Adolescent Participants With Severe Uncontrolled Asthma With an Eosinophilic Phenotype
A 52-week, Randomised, Double-blind, Placebo-controlled, Parallel-group, Multi-centre Study of the Efficacy and Safety of GSK3511294 Adjunctive Therapy in Adult and Adolescent Participants With Severe Uncontrolled Asthma With an Eosinophilic Phenotype
Enrollment Status: Completed
Publish Date: December 17, 2024
Intervention Type: Drug, Biological
Study Drug: GSK3511294
Study Phase: Phase 3
A Phase 3, Double-Blind, Randomized, 8-Week, Vehicle-Controlled Efficacy and Safety Study of Ruxolitinib Cream Followed by a Long-Term Safety Extension Period in Adolescents and Adults With Atopic Dermatitis
A Phase 3, Double-Blind, Randomized, 8-Week, Vehicle-Controlled Efficacy and Safety Study of Ruxolitinib Cream Followed by a Long-Term Safety Extension Period in Adolescents and Adults With Atopic Dermatitis
Enrollment Status: Completed
Publish Date: September 28, 2023
Intervention Type: Drug
Study Phase: Phase 3
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo Controlled, Phase 3b Study to Evaluate the Safety and Efficacy of Benralizumab 30 mg sc in Patients With Severe Asthma Uncontrolled on Standard of Care Treatment
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo Controlled, Phase 3b Study to Evaluate the Safety and Efficacy of Benralizumab 30 mg sc in Patients With Severe Asthma Uncontrolled on Standard of Care Treatment
Enrollment Status: Completed
Publish Date: November 01, 2021
Intervention Type: Drug
Study Phase: Phase 3
Open-Label Study of the Pharmacokinetics and Safety Including HPA Axis Suppression Potential of Clobetasol Topical Oil in Pediatric Subjects With Moderate to Severe Atopic Dermatitis
Open-Label Study of the Pharmacokinetics and Safety Including HPA Axis Suppression Potential of Clobetasol Topical Oil in Pediatric Subjects With Moderate to Severe Atopic Dermatitis
Enrollment Status: Terminated
Publish Date: June 23, 2021
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
View 4 Less Clinical Trials
Similar Doctors
Distinguished in Chronic Spontaneous Urticaria (CSU)
Dr. Bruce D. Finkel
Allergy and Immunology
Distinguished in Chronic Spontaneous Urticaria (CSU)
Dr. Bruce D. Finkel
Allergy and Immunology

Atlanta Allergy & Asthma

790 Church Street Northeast, Suite 150, 
Marietta, GA 
 (191.3 miles away)
770-953-3331
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Bruce Finkel is an Allergy and Immunologist in Marietta, Georgia. Dr. Finkel is rated as a Distinguished provider by MediFind in the treatment of Chronic Spontaneous Urticaria (CSU). His top areas of expertise are Ozena, Nonallergic Rhinopathy, Sinusitis, and Allergic Rhinitis. Dr. Finkel is currently accepting new patients.

Erinn T. Gardner
Distinguished in Chronic Spontaneous Urticaria (CSU)
Dr. Erinn T. Gardner
Allergy and Immunology
Distinguished in Chronic Spontaneous Urticaria (CSU)
Dr. Erinn T. Gardner
Allergy and Immunology

Atlanta Allergy & Asthma

4645 Timber Ridge Drive, Suite 160, 
Douglasville, GA 
 (194.2 miles away)
770-953-3331
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Erinn Gardner is an Allergy and Immunologist in Douglasville, Georgia. Dr. Gardner is rated as a Distinguished provider by MediFind in the treatment of Chronic Spontaneous Urticaria (CSU). Her top areas of expertise are Allergic Rhinitis, Sinusitis, Hives, and Grass Allergy. Dr. Gardner is currently accepting new patients.

Distinguished in Chronic Spontaneous Urticaria (CSU)
Dr. Santhosh K. Kumar
Allergy and Immunology
Distinguished in Chronic Spontaneous Urticaria (CSU)
Dr. Santhosh K. Kumar
Allergy and Immunology

Emory Clinic - Pulmonology At Executive Park

1605 Chantilly Drive Northeast, Ste301, 
Atlanta, GA 
 (178.4 miles away)
404-778-3261
Experience:
24+ years
Languages Spoken:
English, Hindi, Kannada
See accepted insurances
Offers Telehealth

Santhosh Kumar is an Allergy and Immunologist in Atlanta, Georgia. Dr. Kumar has been practicing medicine for over 24 years and is rated as an Advanced provider by MediFind in the treatment of Chronic Spontaneous Urticaria (CSU). His top areas of expertise are Chronic Spontaneous Urticaria (CSU), Vibratory Urticaria, Hives, and Common Variable Immune Deficiency.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Goodman's expertise for a condition
ConditionClose
    View All 14 Advanced Conditions
    View All 9 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile